Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nanosphere NSPH

Healthcare Diagnostics & Research
"Nanosphere Inc develops, manufactures and markets molecular diagnostics platform, the Verigene System, which enables sensitive genomic and protein testing on a single platform."

Recent & Breaking News (NDAQ:NSPH)

Nanosphere, Inc. Announces $10 Million Registered Public Offering

GlobeNewswire December 17, 2015

Nanosphere Announces Record Q3 2015 Results

GlobeNewswire November 9, 2015

Nanosphere to Announce Third Quarter Financial Results & Host Investor Call on Monday, November 9

GlobeNewswire November 2, 2015

Impact of Verigene Blood Culture Tests Highlighted by Five Studies Presented at ICAAC 2015

GlobeNewswire September 22, 2015

Nanosphere Receives FDA Clearance for First-of-Its-Kind Flexible Respiratory Pathogens Test

GlobeNewswire September 8, 2015

Nanosphere Announces Record Q2 2015 Results

GlobeNewswire August 10, 2015

Nanosphere Announces Amendment to $30 Million Term Loan Facility, Release of Q2 2015 Results and Conference Call and Schedules 2015 Annual Meeting of Stockholders

GlobeNewswire July 31, 2015

New Studies Highlight Antibiotic Resistance Detection With Nanosphere's Verigene Blood Culture Tests

GlobeNewswire June 22, 2015

Nanosphere Announces $4.4 Million at the Market Registered Direct Offering

GlobeNewswire June 8, 2015

US Military Accidentally Ships Live Anthrax via FedEx; These Are the Stocks to Watch in Its Wake

Accesswire June 1, 2015

Eighteen New Verigene Clinical and Economic Studies Presented at CVS, ECCMID and MAD-ID 2015

GlobeNewswire May 27, 2015

Nanosphere Announces Closing of New and Expanded Debt Facility and $4.4 Million at the Market Registered Direct Offering

GlobeNewswire May 15, 2015

Nanosphere Announces Record Q1 2015 Results, New and Expanded Debt Facility, $4.4 Million at the Market Registered Direct Offering and Next Generation Verigene System Progress

GlobeNewswire May 11, 2015

Nanosphere Announces Reverse Split of Common Stock

GlobeNewswire April 7, 2015

Scripps Study Illustrates Clinical and Economic Impact of Verigene BC-GP Rapid Blood Culture Test With Antibiotic Stewardship Intervention

GlobeNewswire March 25, 2015

Verigene System Positioned to Provide Rapid Diagnosis of Outbreaks of CRE "Superbugs"

GlobeNewswire March 12, 2015

Nanosphere Announces Special Meeting of Stockholders and Filing of Definitive Proxy Statement With SEC

GlobeNewswire March 3, 2015

Nanosphere Announces Fourth Quarter and Full Year 2014 Results, 2015 Guidance and Next Generation Verigene Progress

GlobeNewswire February 11, 2015

Nanosphere to Release Fourth Quarter & Fiscal Year 2014 Results and Host Investor Conference Call on Wednesday, February 11

GlobeNewswire February 9, 2015

Nanosphere Announces Fourth Quarter and Full Year 2014 Preliminary Top Line Results, Director and Management Changes and Receipt of FDA Warning Letter

GlobeNewswire January 28, 2015